INTERNATIONAL PATENT: NERVIANO MEDICAL SCIENCES S.R.L. FILES APPLICATION FOR "COMBINATION OF A PARP-1 SELECTIVE INHIBITOR AND TEMOZOLIMDE AND ITS USE IN THE TREATMENT OF GLIOMA"

GENEVA, April 19 -- NERVIANO MEDICAL SCIENCES S.R.L. (Viale Pasteur, 1020014 Nerviano (MI)) filed a patent application (PCT/EP2024/077929) for "COMBINATION OF A PARP-1 SELECTIVE INHIBITOR AND TEMOZOLIMDE AND ITS USE IN THE TREATMENT OF GLIOMA" on Oct 04, 2024. With publication no. WO/2025/078276, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MONTAGNOLI, Alessia (Via Ugo Betti, 5120151 Milan), PAPEO, Gianluca Mariano Enrico (Via Monza, 3823870 Cernusco Lombardone (LC))

Abstract: The present invention provides a therap...